HRT can be used in several forms, including pills, skin patches, gels, sprays, and vaginal creams or rings. Health experts recommend women to start HRT within 10 years of menopause or before the age o ...

1. Glucagon-like peptide-1 receptor agonists (GLP-1RA) in combination with progestins are significantly more effective at reducing endometrial cancer (EC) risk compared to progestins alone in female ...

GLP-1RA therapy plus progestin therapy is associated with a significantly reduced endometrial cancer risk (HR, 0.34; 95% CI, 0.27-0.44) compared to progestin therapy only. For patients with ...

About The Study: In this cohort study of women with benign uterine pathology or endometrial hyperplasia, combined glucagon-like peptide-1 receptor agonist (GLP-1RA) and progestin was associated with ...

Improved patient care is needed to reduce cancer risk among women with a condition that causes excessive thickening of the womb lining, research shows. Tamoxifen treatment is associated with increased ...

ABSTRACT: A total of 157 patients were included in this study, comprising 147 with simple Endometrial Hyperplasia (EH) and 10 with complex EH. All patients treated cyclically with progestin or ...

1 Department of Obstetrics & Gynecology, Gujo City Hospital, Gujo City, Japan. 2 Department of Obstetrics & Gynecology, Central Japan International Medical Center, Minokamo City, Japan. 3 Department ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing ...

Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the ...

(a) The tumor shows focal glandular architecture along with solid areas (100×, H&E). (b, c) The solid component exhibits prominent lymphocytic infiltrate with tumor heterogeneity (100×, H&E). (d) The ...